SEC 13F Intelligence

Exome Asset Management LLC / ONC

Exome Asset Management LLC’s Beone Medicines Ltd Position

Does Exome Asset Management LLC own Beone Medicines Ltd (ONC)? Not currently — the last reported position was 6.5K shares worth $2M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q1 2025
Shares
6.5K
% of Portfolio
+1.57%
Quarters Held
6
position exited

Position History ONC

Reported value by quarter
Q4 ’23: $2MQ4 ’23Q1 ’24: $6MQ1 ’24Q2 ’24: $5MQ2 ’24Q3 ’24: $7MQ3 ’24Q4 ’24: $2MQ4 ’24Q1 ’25: $2MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20256.5K$2M+1.57%
Q4 202410.0K$2M+1.39%
Q3 202430.6K$7M+2.34%
Q2 202433.2K$5M+4.22%
Q1 202436.8K$6M+4.93%
Q4 202312.8K$2M+2.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exome Asset Management LLC’s full portfolio or all institutional holders of ONC.